Tapering off Wellbutrin (bupropion) means gradually lowering your dose in planned steps with your prescriber's guidance instead of stopping suddenly. Wellbutrin may cause fewer discontinuation symptoms than some other antidepressants such as selective serotonin reuptake inhibitors (SSRIs), However, a gradual approach can help you monitor your mood and recognize returning depression symptoms.
Whether you're feeling better, dealing with side effects, or planning a medication switch, it's natural to have questions about what coming off Wellbutrin might feel like. Understanding the process can help you feel more prepared to discuss your options with your provider.
Key Takeaways
Discontinuation symptoms are possible but may be less common with Wellbutrin: Roughly 1 in 3 people who stop an antidepressant report symptoms, and the limited evidence available suggests bupropion carries a lower risk than many SSRIs.
The recommended taper depends on your dose and formulation: For people taking Wellbutrin XL 300 mg once daily, official prescribing information advises reducing from 300 mg to 150 mg before stopping, and extended-release tablets should not be cut or crushed.
Monitoring your mood can help you recognize relapse early: Choosing an appropriate time, tracking your mood, and scheduling follow-ups can help you catch a return of depression early.
What Is Wellbutrin?
Wellbutrin is the brand name for bupropion, a prescription medication used to treat major depressive disorder and seasonal affective disorder. It is also sold under the brand name Zyban to help people quit smoking.
Before planning a taper, it helps to understand how Wellbutrin differs from other antidepressants and which formulation you take, since both can affect how your dose is reduced.
How Wellbutrin Works
Unlike SSRIs such as Zoloft or Lexapro, Wellbutrin isn't thought to act mainly on serotonin. Researchers believe it works by slowing the reabsorption of norepinephrine and dopamine, two brain chemicals involved in mood, energy, and motivation.
This different mechanism is one reason Wellbutrin isn't an SSRI and why it has a different side effect profile, including a lower risk of sexual side effects than many SSRIs.
Wellbutrin Formulations
Bupropion comes in several versions, and the form you take can affect how a taper is planned:
Immediate-release (IR): Usually taken several times a day; less commonly prescribed today.
Sustained-release (SR): Usually taken twice daily, with available strengths of 100 mg, 150 mg, and 200 mg tablets.
Extended-release (XL): Usually taken once daily, with common tablet strengths of 150 mg and 300 mg tablets.
SR and XL tablets must be swallowed whole and should not be split, crushed, or chewed. This means tapering often involves switching tablet strengths or formulations rather than cutting pills.
Why Taper Off Wellbutrin Instead of Stopping Suddenly?
Because Wellbutrin works differently from many other antidepressants, some people may assume that stopping it suddenly is safe. While Bupropion may carry a relatively lower risk of discontinuation symptoms, symptoms can still occur. A planned taper also gives you and your prescriber a chance to monitor your mood and watch for signs of returning depression.
What Prescribing Information Says
Official Wellbutrin XL prescribing information advises that people taking 300 mg once daily reduce the dose to 150 mg once daily before stopping. For people taking it for seasonal affective disorder, the label recommends tapering and stopping in early spring.
The Wellbutrin SR label doesn't include a specific taper schedule. However, its Medication Guide advises talking to a healthcare provider before stopping treatment.Your prescriber can help determine an appropriate approach based on your dose and formulation.
Protecting Against Relapse
Tapering off Wellbutrin gradually also gives you and your provider time to notice whether depression symptoms are returning. In a large UK study of people who felt well while taking long-term antidepressants, 56% of those who stopped had a relapse within a year, compared with 39% of those who continued.
These findings apply to antidepressants overall, not specifically to Wellbutrin. Your personal risk of relapse depends on factors such as your history of depression, how long you've been feeling well, and previous episodes.
Possible Wellbutrin Discontinuation Symptoms
Discontinuation symptoms after stopping bupropion appear to be less common than with some SSRIs, but they have been reported. A published case report described irritability, anxiety, insomnia, headache, and body aches after someone stopped bupropion abruptly.
Symptoms some people may notice when reducing or stopping Wellbutrin include:
Irritability or mood swings: Feeling more on edge or emotionally reactive than usual.
Anxiety or restlessness: A sense of unease that may feel new or stronger than before.
Sleep changes: Trouble falling asleep, or unusually vivid dreams.
Headaches and body aches: Mild physical discomfort, sometimes with a flu-like feeling.
Low energy or low mood: Fatigue or sadness, which can overlap with returning depression.
Across antidepressants generally, discontinuation symptoms often begin within a few days and typically last a few weeks. Restarting the previous dose often eases symptoms quickly. If symptoms become difficult to manage, contact your prescriber. Adjusting the taper may help, but don't restart or change your dose without medical guidance.
How Common Are Antidepressant Discontinuation Symptoms?
Research on discontinuation symptoms has mostly focused on SSRIs and serotonin-norepinephrine reuptake inhibitors (SNRIs), so data specific to bupropion is limited. Still, the broader research can offer some context for what people may experience when stopping treatment.
What Large Studies Show
A 2024 meta-analysis of 79 studies involving more than 21,000 people found that about 31% of those who stopped an antidepressant reported at least one discontinuation symptom, compared with 17% of those who stopped a placebo. Severe symptoms were less common, affecting about 2.8% of people.
An earlier systematic review reported higher estimates and found that symptoms sometimes lasted longer than two weeks. Estimates vary across studies, partly because of differences in medications, study methods, and treatment duration.
Where Bupropion Fits
A clinical review rated bupropion XL as having a low risk of discontinuation syndrome compared with medications like paroxetine and venlafaxine. However, the authors noted that data on bupropion is limited, so a low risk doesn't mean no risk.
How a Wellbutrin Taper Typically Works
There is no single validated tapering schedule for antidepressants that works for everyone. The plans are tailored to each person. Your prescriber will consider your dose, formulation, how long you've taken Wellbutrin, and why you're stopping when planning dose reductions.
Stepping Down Your Dose
For many people on Wellbutrin XL, a taper may involve moving from 300 mg to 150 mg for a period of time before stopping. People on SR or higher doses may step down through available tablet strengths, sometimes switching formulations along the way.
Clinical guidelines recommend reducing antidepressants in stages, with further reductions guided by how well you tolerate each step. Your prescriber can help determine the pace and whether you need more time between dose changes.
Slower Tapers When Needed
Some research on SSRIs suggests that tapers lasting several months, with smaller reductions near the end, may be better tolerated than quick tapers. However, this evidence doesn't establish the ideal taper schedule for bupropion.
Because bupropion's extended-release tablets can't be cut, crushed, or split, very gradual tapers may be harder to arrange. Your prescriber can help determine whether a slower taper or a different formulation is appropriate for you.
Switching to Another Medication
If you're stopping Wellbutrin to start a different medication, your prescriber may recommend a gradual transition. Depending on the medications involved, this could include overlapping them for a period while adjusting their doses, a process known as cross-tapering. This can help keep your mood steady during the transition.
Cross-tapering isn't appropriate for every medication combination. Your prescriber can determine whether overlapping treatments is safe or whether it's better to stop one medication before starting the other.
Tips for a Smoother Wellbutrin Taper
Alongside your prescriber's plan, a few practical habits may help you manage the transition:
Choose a calm period: Avoid starting a taper during a major life change, a stressful work season, or, for seasonal depression, the darker months.
Track your mood and sleep: A daily log can help you and your provider tell short-term withdrawal from returning depression.
Keep your routines steady: Regular sleep, meals, physical activity, and time outdoors can support your mood.
Don't double up or skip doses: Taking extra bupropion to make up for missed doses can raise seizure risk, which is dose-related.
Line up support: Let someone you trust know you're tapering, and consider therapy for added tools during the transition.
Schedule a follow-up: Plan check-ins with your prescriber during and after the taper.
It can also help to know what improvement looked like for you on the medication. Reviewing the signs Wellbutrin is working may make it easier to notice if those improvements begin to fade.
When to Seek Medical Attention
Most people taper off Wellbutrin without serious problems, but certain symptoms need prompt attention. Contact your provider or seek emergency care if you notice:
Thoughts of suicide or self-harm: Call or text 988 for support, or call 911 if you’re in immediate danger.
A seizure: Bupropion can increase seizure risk. Seek emergency medical care if a seizure occurs.
Returning depression: Persistent sadness, hopelessness, or loss of interest that lasts more than a couple of weeks.
Unusual changes in mood or behavior: Severe agitation, panic, aggression, or unusually high energy and racing thoughts.
Symptoms that disrupt daily life: Anything that makes it hard to work, sleep, or care for yourself.
Antidepressant labels carry a warning about increased suicidal thoughts in children, teens, and young adults. Close monitoring is especially important when changing a dose or stopping treatment.
How Blossom Health Can Help You Taper Off Wellbutrin
Tapering off Wellbutrin is easier with a provider who can tailor the plan to your formulation, dose, and medical history. Blossom Health connects you with board-certified, licensed psychiatric providers for virtual, in-network care, including medication management.
During your first hour-long video visit, your provider can help review your symptoms, medication history, and treatment goals. Together, you can decide whether tapering makes sense now, build a step-by-step plan, or explore a switch to another medication if Wellbutrin isn't the right fit.
If you're ready to talk about your treatment, you can schedule a visit and may be able to get an appointment within days. Coverage varies by plan, so check your benefits when you book.
Medical Disclaimer
This article is for informational purposes only and is not a substitute for professional medical advice. Never stop or change your medication without talking to your healthcare provider. If you are in crisis, call or text 988 to reach the 988 Suicide and Crisis Lifeline, or call 911 in an emergency.
Sources
1. U.S. Food and Drug Administration. (November 2025). Wellbutrin XL (bupropion hydrochloride extended-release tablets) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/021515s049lbl.pdf
2. U.S. Food and Drug Administration. (November 2025). Wellbutrin SR (bupropion hydrochloride sustained-release tablets) prescribing information. https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/020358s070lbl.pdf
3. Huecker MR, Smiley A, Saadabadi A. (September 02, 2024). Bupropion. StatPearls, NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK470212/
4. MedlinePlus, National Library of Medicine. (November 15, 2025). Bupropion. https://medlineplus.gov/druginfo/meds/a695033.html
5. Henssler J, Schmidt Y, Schmidt U, Schwarzer G, Bschor T, Baethge C. (2024). Incidence of antidepressant discontinuation symptoms: A systematic review and meta-analysis. The Lancet Psychiatry, 11(7), 526 to 535. PMID: 38851198. https://pubmed.ncbi.nlm.nih.gov/38851198/
6. Davies J, Read J. (2019). A systematic review into the incidence, severity and duration of antidepressant withdrawal effects: Are guidelines evidence-based? Addictive Behaviors, 97, 111 to 121. PMID: 30292574. https://pubmed.ncbi.nlm.nih.gov/30292574/
7. Horowitz MA, Taylor D. (2019). Tapering of SSRI treatment to mitigate withdrawal symptoms. The Lancet Psychiatry. https://markhorowitz.org/academic-paper/tapering-of-ssri-treatment-to-mitigate-withdrawal-symptoms/
8. Berigan TR, Harazin JS. (1999). Bupropion-associated withdrawal symptoms: A case report. Primary Care Companion to the Journal of Clinical Psychiatry, 1(2), 50 to 51. https://psychiatrist.com/pcc/bupropion-associated-withdrawal-symptoms-case-report
9. Zwiebel SJ, Viguera AC. (2022). Discontinuing antidepressants: Pearls and pitfalls. Cleveland Clinic Journal of Medicine, 89(1), 18 to 26. https://www.ccjm.org/content/89/1/18
10. National Institute for Health and Care Excellence. (2023). Quality statement 4: Stopping antidepressants (QS8). https://www.nice.org.uk/guidance/qs8/chapter/Quality-statement-4-Stopping-antidepressants
11. University of Bristol. ( October 04, 2021). Staying on long-term antidepressants reduces risk of relapse (summary of Lewis G, et al. Maintenance or discontinuation of antidepressants in primary care. New England Journal of Medicine, 2021;385(14):1257 to 1267. PMID: 34587384). https://www.bristol.ac.uk/primaryhealthcare/news/2021/staying-on-long-term-antidepressants-reduces-risk-of-relapse.html
12. Mayo Clinic. (June 22, 2026). Antidepressant withdrawal: Is there such a thing? https://www.mayoclinic.org/endocrine-system/expert-answers/faq-20058133
13. Cleveland Clinic. (August 30, 2023). Antidepressant discontinuation syndrome. https://my.clevelandclinic.org/health/diseases/25218-antidepressant-discontinuation-syndrome
